Related Experiment Video
Updated: Sep 16, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Considerations for Patient-reported Outcomes in the Management of Metastatic Renal Cell Carcinoma
Andrew Schlager1, Jasnoor Malhotra1, Cristiane Decat Bergerot2
1Saint Louis University School of Medicine, St. Louis, MO, USA.
Abstract:
Selection of the most appropriate patient-reported outcome measures is essential for accurate assessment of wellbeing in metastatic renal cell carcinoma (RCC). Existing tools provide useful information, but a more nuanced and comprehensive approach is necessary to capture the full scope of patient experiences. FKSI-23 is a new tool with distinct scoring options for localized and advanced RCC. Pending validation, its adoption could better align clinical evaluation with the realities of patients' lived experiences.
More Related Videos
Related Concept Videos
Kidney Transplant III: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Cancer Survival Analysis
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Urinary Tract Calculi V: Nursing Management

